• 🌎 Worldwide
    • 🇺🇸 U.S.
    • 🇨🇦 Canada
    • 🇬🇧 United Kingdom
    • 🌏 Asia
    • 🌍 Europe
    • 🌎 Latin America
    • 🌏 Oceania and Australasia
The Daily Marijuana Observer
SUBSCRIBE
  • Home
  • Latest
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
  • Home
  • Latest
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
No Result
View All Result
Home People Doctors

5 Commonly Prescribed Drugs With the Same DEA Classification as EPIDIOLEX

Steven Lachard by Steven Lachard
October 5, 2018
in Doctors, Health, Patients
Schedule V Drugs - package of 150mg Lyrica
198
SHARES
ShareShare

The U.S. Drug Enforcement Administration, a.k.a. the DEA, recently classified the CBD-based EPIDIOLEX® oral solution from GW Pharmaceuticals plc (NASDAQ:GWPH) as Schedule V, the lowest restriction classification.

$32,500 per year EPIDIOLEX®, which was approved by the FDA on June 25th for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients two years of age or older, is the first prescription pharmaceutical formulation of highly-purified, non-psychoactive, plant-derived cannabidiol, and the first in a new category of anti-epileptic drugs.

While marijuana is still sitting alongside heroin in the Schedule 1 category, now categorized as Schedule V, CBD-based EPIDIOLEX® joins some of the most commonly prescribed pharmaceuticals in the United States. This is a step in the right direction, but still leaves all other marijuana-based medicine sitting in no-man’s land.

The crazy part is, marijuana and its naturally occurring cannabinoids such as CBD are all way safer than just about every other drug under the Schedule V classification.

5 Common Schedule V Substances

According to the DEA, “Schedule V drugs, substances, or chemicals are defined as drugs with lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. Schedule V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes.”

One commonly known example of a Schedule V substance is promethazine with codeine. Additionally, Schedule V covers combinations of calcium and codeine, as well as combinations of pseudoephedrine with codeine.

You know that ultra-addictive sizzurp that Lil’ Wayne and other rappers drink out of a styrofoam cup? That’s the stuff!

Schedule V Drug Classification
Photo Credit – daddyboskeazy via Flickr

Another well-known Schedule V drug is Lyrica (Pregabalin), which is used to treat pain associated with diabetic peripheral neuropathy and spinal cord injuries, as well as fibromyalgia and more. Even though Lyrica is far less dangerous than cough syrups containing codeine, the scary side effects will make you wonder why weed is still Schedule I. Meanwhile, marijuana is already proving to be beneficial for some patients with fibromyalgia.

A quick read through the side effects of Lomotil (Diphenoxylate and Atropine), a commonly-prescribed anti-diarrhetic, sounds like it gets you higher than ten hits of Captain Krypt. According to WebMD, common side effects of Lomotil include drowsiness, dizziness, headache, tiredness, blurred vision, and dry mouth.

The next most commonly known Schedule V substance on our list, Motofen, is another anti-diarrhetic which has nearly identical side effects to Lomotil.

Last, but not least, is Parepectolin which commonly causes flatulence, and nausea​. Although it sounds like Parepectolin causes the same mess that a drunken 2 A.M. trip to Taco Bell does, it is actually prescribed to stop diarrhea.

Conclusion

For fairness sake, the FDA-approved labeling for EPIDIOLEX® warns that it can potentially change patients’ appetites or cause drowsiness, weakness, lethargy, and more. All things considered, those side effects sound like a small price to pay for fewer or less-severe seizures.

Once marijuana is eventually re-scheduled, more research can be conducted to definitively prove pot’s efficacy for various conditions and ailments. Until then, be sure to subscribe to free Cannabis Industry Updates here so you never miss an important update.

Share this:

  • Click to email this to a friend (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on Tumblr (Opens in new window)
  • Click to share on Pocket (Opens in new window)
Tags: EpidiolexGW Pharmaceuticals Plc.NASDAQ:GWPH

Get Real-Time Updates from MJobserver.com

Unsubscribe
Steven Lachard

Steven Lachard

Steven Lachard is a staff writer for MJobserver.com with a particular focus on marijuana stocks. Beyond MJobserver.com, Steven's pot stock insights have been featured on TalkMarkets.com and more.

Related Posts

Epidiolex from GW Pharmaceuticals
Investments

Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader

February 3, 2021
Epidiolex from GW Pharmaceuticals
Investments

Greenwich Biosciences, Inc., a Subsidiary of GW Pharmaceuticals plc, Launches unspoken symphony, a Breakthrough Innovation Created for the US Epilepsy Community

October 21, 2020
Epidiolex from GW Pharmaceuticals
Executives

GW Pharmaceuticals Announces the Appointment of David Gryska to its Board of Directors

September 10, 2020
Cannabis News - Marijuana Becomes Legal in Michigan Starting December 6th
Press Releases

GW Pharmaceuticals to Host Virtual Investor Event on Its Nabiximols U.S. Development Program and Market Opportunity

June 4, 2020
Bank of America Merrill Lynch Marijuana Stock Research Coverage
Events

GW Pharmaceuticals to Present at the Bank of America Healthcare Conference 2020

May 1, 2020
Epidiolex from GW Pharmaceuticals
Investments

GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the First Quarter Ending March 31st, 2020 and Host Conference Call on May 11th, 2020

April 21, 2020
Load More
Next Post
Pepsi Joining the Green Rush with Release of Cannabis-Infused Sodas?

Will Pepsi Be Next To Join Marijuana’s Green Rush?

Comments 1

  1. Pingback: 3 ETFs Offering Exposure To The Canadian Green Rush - The Fresh Toast

Leave a Comment! Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

📰 Recent News

  • J. Arnold Wealth Management Discloses New Stake in Cannabis ETF
  • Bank of America Increases its SNDL Holdings
  • The Lift & Co. Expo is back helping Canada build responsible, prosperous cannabis and psychedelics businesses
  • Bank of America Trims its Stake in Canopy Growth Corp.
  • Ballard Spahr Launches Cannabis Legislation Tracker to ID Industry Trends and Opportunities
Facebook Twitter Instagram LinkedIn Youtube

Cannabis News by Region

  • 🇺🇸 United States
  • 🇨🇦 Canada
  • 🇬🇧 United Kingdom
  • 🌏 Asia
  • 🌍 Europe
  • 🌎 Latin America
  • 🌏 Oceania and Australasia

Cannabis Tools & Resources

  • 📅 Calendar
  • 📊 Databases
  • 📇 Directories
  • 🔔 RSS Feeds
  • 📺 Videos

Find Cannabis Business Services

  • ⚖️ Attorneys & Law Firms
  • 📊 Accountants & Accounting Firms
  • 💡 Consultants & Consulting Firms
  • 📲 Marketing Agencies & Firms

The Daily Marijuana Observer

  • Subscribe
  • About MJobserver.com
  • Affiliate Marketing Disclosure
  • Legal Disclaimer
  • Privacy Policy
  • Contact Us

Advertise with Us

  • 👀 Advertise
  • 📣 DMO Newswire
  • 📇 List in Our Databases

© 2018 - 2021 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observer™ (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

No Result
View All Result
  • Home
  • Latest
  • 🔒 PRO
    • 🔒 A.M. Watchlist
    • 🔒 Analyst Action
  • 💼 Business
  • 📈 Investments
    • 📈 Stocks
    • 💰 ETFs and Funds
    • 💭 Market Commentary
    • 📰 Press Releases
    • 📅 Earnings Calendar
  • ⚖️ Law
    • Laws
    • Politics
    • Intellectual Property
    • Attorneys & Law Firms Database
  • 👥 People
    • ⚽ Athletes
    • 💼 Executives
    • 🌟 Celebrities
    • 🛒 Consumers
    • ⚕️ Doctors
    • 💊 Patients
  • 💊 Health
  • 📇 Databases
    • 📈 Stock Databases
    • 💰 Fund Databases
    • 💼 Service Providers Databases
    • 🏦 Marijuana Stock Brokers
    • 💲 Marijuana Cryptocurrencies

© 2018 - 2021 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observer™ (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

Login to your account below

Forgotten Password? Sign Up

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.